Palmira Foro, MD, PhD

Disclosure:
No relationships to disclose.

Presentation(s):

• 204 - A Phase IIB Trial of Docetaxel Concurrent With Radiation Therapy Plus Hormonotherapy Versus Radio Hormonotherapy in High-Risk Localized Prostate Cancer: Late Toxicity Analysis

  Tuesday, October 23
  3:45 PM – 3:55 PM